MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 120 filers reported holding MAXCYTE INC in Q3 2023. The put-call ratio across all filers is 10.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $136,082 | -29.5% | 43,616 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $193,078 | -8.3% | 42,065 | -1.1% | 0.00% | 0.0% |
| Q1 2023 | $210,543 | -6.3% | 42,534 | +3.3% | 0.00% | -50.0% |
| Q4 2022 | $224,717 | -16.5% | 41,157 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $269,000 | +39.4% | 41,308 | +1.4% | 0.00% | +100.0% |
| Q2 2022 | $193,000 | -44.4% | 40,725 | -17.9% | 0.00% | -50.0% |
| Q1 2022 | $347,000 | -33.3% | 49,612 | -2.7% | 0.00% | -33.3% |
| Q4 2021 | $520,000 | +395.2% | 50,999 | +494.7% | 0.00% | +200.0% |
| Q3 2021 | $105,000 | – | 8,576 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTH RUN CAPITAL, LP | 480,900 | $3,361,000 | 4.94% |
| Casdin Capital, LLC | 13,971,334 | $97,660,000 | 4.38% |
| Vitruvian Partners LLP | 4,385,670 | $30,656,000 | 3.25% |
| RIVER GLOBAL INVESTORS LLP | 2,100,000 | $14,849,000 | 1.95% |
| APIS CAPITAL ADVISORS, LLC | 180,000 | $1,258,000 | 1.52% |
| Pier Capital, LLC | 1,017,753 | $7,114,000 | 0.91% |
| First Light Asset Management, LLC | 1,321,406 | $9,237,000 | 0.82% |
| Montanaro Asset Management Ltd | 929,000 | $6,557,000 | 0.81% |
| Nicholas Investment Partners, LP | 776,963 | $5,431,000 | 0.39% |
| Bleichroeder LP | 250,000 | $1,764,000 | 0.31% |